Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses MRD As A Surrogate Marker In CLL. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses MRD As A Surrogate Marker In CLL. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com